CD4 and COVID-19: Another systematic review on immunity and inflammatory biomarkers in COVID19 (Iwamura et al., 2021), demonstrated low counts of CD3+ and CD4+ T cells and lymphocytes, especially in severe and critical COVID19 patients, while an erythrocyte sedimentation rate (ESR), CRP and IL6 were elevated, independent of the severity of disease.